Michele Zoli

Prof. Michele Zoli


Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1998 in Nature
Verified
Journal Article
Closed access
PDF file
MPMarina R. Picciotto
Marina R. Picciotto
MZMichele Zoli
Michele Zoli
RRrimondini roberto
rimondini roberto
CLClément Léna
Clément Léna
LMLisa M. Marubio
Lisa M. Marubio
JCJean-Pierre Changeux
Jean-Pierre Changeux

1 September 2006 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
CGCecilia Gotti
Cecilia Gotti
MZMichele Zoli
Michele Zoli
FCFrancesco Clementi
Francesco Clementi

1 March 2001 in Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
RKRuby Klink
Ruby Klink
ADAlban de Kerchove D'EXaerde
Alban de Kerchove D'EXaerde
MZMichele Zoli
Michele Zoli
JCJean-Pierre Changeux
Jean-Pierre Changeux
Nicotinic acetylcholine receptors (nAChRs) on dopaminergic (DA) and GABAergic (Gaba) projection neurons of the substantia nigra (SN) and ventral tegmental area (VTA) are characterized by single-cell RT-PCR and patch-clamp recordings in slices of rat and wild-type, β2−/−, α4−/−, and α7−/− mice. The eight nAChR subunits expressed in these nuclei, α3–7 and β2–4, contribute to four different types of nAChR-mediated currents. Most DA neurons in the SN and VTA express two nAChR subtypes. One is inhibited by dihydro-β-erythroidine (2 μm), α-conotoxin MII (10 nm), and methyllycaconitine (1 nm) but does not contain the α7 subunit; it possesses a putative α4α6α5(β2)2 composition. The other subtype is inhibited by dihydro-β-erythroidine (2 μm) and has a putative α4α5(β2)2 composition. Gaba neurons in the VTA exhibit a third subtype with a putative (α4)2(β2)3 composition, whereas Gaba neurons in the SN have either the putative (α4)2(β2)3 oligomer or the putative α4α6α5(β2)2 oligomer. The fourth subtype, a putative (α7)5 homomer, is encountered in less than half of DA and Gaba neurons, in the SN as well as in the VTA. Neurons in the DA nuclei thus exhibit a diversity of nAChRs that might differentially modulate reinforcement and motor behavior.

1 March 1995 in Nature
Verified
Journal Article
Closed access
MPMarina R Picciotto
Marina R Picciotto
MZMichele Zoli
Michele Zoli
CLClement Léna
Clement Léna
ABAlain Bessis
Alain Bessis
YLYvan Lallemand
Yvan Lallemand
JCJean-Pierre Changeux
Jean-Pierre Changeux

1 December 1995 in Neuroscience
Verified
Journal Article
Closed access
LAL.F. Agnati
L.F. Agnati
MZMichele Zoli
Michele Zoli
ISI. Strömberg
I. Strömberg
KFKjell Fuxe
Kjell Fuxe

1 May 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JHJoëlle Hillion
Joëlle Hillion
MCMeritxell Canals
Meritxell Canals
MTMaria Torvinen
Maria Torvinen
VCVicent Casadó
Vicent Casadó
RSRizaldy Scott
Rizaldy Scott
KFKjell Fuxe
Kjell Fuxe
Antagonistic and reciprocal interactions are known to exist between adenosine and dopamine receptors in the striatum. In the present study, double immunofluorescence experiments with confocal laser microscopy showed a high degree of colocalization of adenosine A2A receptors (A2AR) and dopamine D2 receptors (D2R) in cell membranes of SH-SY5Y human neuroblastoma cells stably transfected with human D2R and in cultured striatal cells. A2AR/D2R heteromeric complexes were demonstrated in coimmunoprecipitation experiments in membrane preparations from D2R-transfected SH-SY5Y cells and from mouse fibroblast Ltk− cells stably transfected with human D2R (long form) and transiently cotransfected with the A2AR double-tagged with hemagglutinin. Long term exposure to A2AR and D2R agonists in D2R-cotransfected SH-SY5Y cells resulted in coaggregation, cointernalization and codesensitization of A2AR and D2R. These results give a molecular basis for adenosine-dopamine antagonism at the membrane level and have implications for treatment of Parkinson's disease and schizophrenia, in which D2R are involved.